Earnings Call Transcript Summaries

Gujarat Fluorochemicals Limited FLUOROCHEM Q1FY27 📝 Transcript · Chemicals

Filed 19 Aug 2026

Fluorochemical revenue surged 52% y-y led by R32 refrigerant sales; R32 capacity expansion expected Q2 FY27
New fluoropolymer approvals expected by FY27 end enabling faster capacity ramp-up
Full utilization expected for incremental R32 capacity in calendar year 2027
Capex plan: INR 2,300 Cr for EV and INR 800 Cr for chemical business in FY27
Q1 FY27 consolidated revenue grew 24% y-y to INR 1,588 Cr; EBITDA up 24% to INR 428 Cr; PAT rose 19% to INR 219 Cr
Battery materials progressing; significant revenue ramp-up expected from Q4 FY27 and FY28

EMS Limited EMSLIMITED Q1FY27 📝 Transcript

Filed 19 Aug 2026

No CAPEX plans currently; Q2 weaker than Q1 but Q3 and Q4 expected to show strong growth
Q1 FY27 standalone revenue Rs. 125.72 Cr (+50% q-q), EBITDA margin 25.53%, PAT Rs. 15.03 Cr (+184.65% q-q)
Working capital cycle approx. 120 days; revenue ramp-up and margin recovery expected in H2 FY27
Execution on West Bengal project expected to normalize from Q3 FY27
FY27 revenue guidance: Rs. 900-950 Cr, with 50% growth over last year; margins expected to return to 2024-25 levels
Project timelines typically 2-3 years; revenue starts 6-7 months post work order

Aegis Vopak Terminals Limited AEGISVOPAK Q1FY27 📝 Transcript · Oil Gas & Consumable Fuels

Filed 19 Aug 2026

Management targets 25% y-y volume growth; sourcing diversified globally to mitigate geopolitical risks
Multimodal evacuation and pipeline connectivity projects progressing, supporting volume growth
Capex of INR10,000 Cr expected by FY27 end; $5bn capex target by FY31 funded by mix of equity, debt, and accruals
Q1 FY27 revenue from operations rose 12.4% y-y to INR233.8 Cr; liquid terminaling up 31%, gas terminaling down 3.5%
Multiple pipeline projects to enhance evacuation and distribution, including Haldia-Panagarh and Kandla-Gorakhpur
Major capacity expansions underway at JNPA, Kochi, Kandla, Pipavav, Mangalore; new ammonia terminal commissioned

Rico Auto Industries Limited RICOAUTO Q1FY27 📝 Transcript

Filed 19 Aug 2026

Air freight costs expected to peak in Q2, normalize by Q3; customer price revisions underway
Capex focused on small expansions; major projects paused to stabilize current assets
Q1 FY27 consolidated revenue grew 39% y-y to INR755 Cr; EBITDA INR34.8 Cr (4.6% margin); PAT loss INR3.4 Cr
Railways and defense businesses progressing; RDSO approvals ongoing; 200 defense ranges to be supplied in FY27
FY27 revenue guidance raised to INR3,200-3,250 Cr; margins expected to improve to near 10% by H2
CNC machine sales initiated; target 100 units in FY27 adding ~INR35-40 Cr revenue

Rubicon Research Limited RUBICON Q1FY27 📝 Transcript · Healthcare

Filed 19 Aug 2026

Q1 FY27 revenue INR534 Cr +51% y-y; EBITDA INR131 Cr +65% y-y; PAT INR85 Cr +95% y-y
EBITDA margin guided upwards to 23% for FY27 from earlier 22-23%
Gross margin improved sequentially by 140 bps to 67.7% despite input cost rise
R&D spend at 10.9% of revenue; productivity at 5.5x; INR500 Cr spend guidance on track
Pithampur facility FDA approved; ramp-up expected from Q1 CY27; significant expansion headroom
Arinna acquisition contributed INR12 Cr revenue; EBITDA impact immaterial

Stanley Lifestyles Limited STANLEY Q1FY27 📝 Transcript

Filed 19 Aug 2026

Q1 FY27 revenue at INR 99.35 Cr, down from INR 108.61 Cr in Q1 FY26 due to Middle East war logistics and delayed residential handovers
Pre-Ind AS gross margin ~56-60%, EBITDA margin 11-13%; corporate cost ~INR 0.9 Cr/month
Order book INR 68 Cr as of June 30, 2026
EBITDA INR 17.22 Cr with 17.3% margin; PAT INR 0.65 Cr
35 of 42 COCO stores EBITDA positive; new stores EBITDA positive within 6-12 months; ROI in 24-36 months
Manufacturing utilization at 68-70%; inventory higher in Q1 due to seasonal factors

Minda Corporation Limited MINDACORP Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 19 Aug 2026

Capex guidance ~400 Cr for FY27, spread across business verticals
Q1 FY27 revenue 1846 Cr +33.2% YoY; EBITDA 212 Cr +35.4% YoY; margin 11.5%; PAT 206 Cr +216% YoY
Flash Electronics targets 20-24% growth with 16-17% margin long term
Wiring harness and instrument cluster divisions grew 30-35% YoY; growth expected to continue
SOPs for Turntide motor controller and sunroof business on track for Q3/Q4 FY27
Management confident of achieving Vision 2030 targets with focus on premiumization, exports, and R&D

Orient Technologies Limited ORIENTTECH Q1FY27 📝 Transcript

Filed 19 Aug 2026

Order book at 375.43 Cr, up from 200 Cr in Q4 FY26; billing expected mainly in Q3-Q4 FY27
IPO capex utilization at 35 Cr remaining, expected to be deployed in next quarters
Q1 FY27 revenue 201.92 Cr, +9.7% QoQ; EBITDA 15.42 Cr, +161% QoQ; EBITDA margin 7.57%, +438 bps QoQ; PAT 5.17 Cr vs loss in Q4 FY26
Sustainable EBITDA margin expected around current levels due to operational efficiency and margin-led deals
OHMS 2.0 offers outcome-based managed services with cost savings; DaaS gaining traction as OPEX model
Annuity revenue at 23%, targeted to reach 51% over 3 years via NOC/SOC and managed services

Centum Electronics Limited CENTUM Q1FY27 📝 Transcript · Capital Goods

Filed 18 Aug 2026

Stand-alone Q1 FY27 revenue grew 11% y-y to INR205 Cr; EBITDA margin 11.28%, PAT margin 6.59%
FY27 revenue growth guidance maintained at 25%+; margin target above 13%
EMS revenue grew 20% y-y; semiconductor equipment revenue ramped to >INR100 Cr in FY26, expected to double in 1-2 years
Export share expected to remain ~50-55%; EMS margins ~10-11%, BTS margins ~20%+
Progress on defense and space programs including Virupaksha, UHM, TACAN with prototypes expected next year
BTS order book grew 40% y-y; strong order intake of INR360 Cr (+70% y-y) with BTS up 150%

PI Industries Limited PIIND Q1FY27 📝 Transcript · Chemicals

Filed 18 Aug 2026

New molecule pipeline includes ~90 projects; 4-5 product launches planned in FY27
Pioxaniliprole insecticide launch expected in India within FY27; global launches later
Capex guidance Rs 700-800 crore for FY27; investments in manufacturing and innovation
Q1 FY27 revenue Rs 17,023 million; gross margin 57%, EBITDA margin 22%
Export business challenged by global industry downturn; recovery expected H2 FY27
Domestic agrochem volume grew 12%, biologicals up 50% with 3-year CAGR 15%

Astral Limited ASTRAL Q1FY27 📝 Transcript · Capital Goods

Filed 18 Aug 2026

Adhesive India grew 24.9% in Q1; margin pressure in Q1 due to inventory cost; margin expected to recover to 15-17%
Q1 FY27: Flat volume growth in plumbing vs industry -10%; 10% value growth; EBITDA margin 18.9%
Plumbing volume growth guidance: minimum double-digit for FY27; EBITDA margin guidance 16-18%
Capex of INR137 Cr in Q1; FY27 capex guidance INR300-350 Cr
UK adhesive grew 26% with EBITDA margin improving to 4.9%; full-year margin target 8-10%
Paint business grew 48.7%, EBITDA breakeven; 20-25% revenue growth guidance for FY27

Saatvik Green Energy Limited SAATVIKGL Q1FY27 📝 Transcript · Capital Goods

Filed 18 Aug 2026

Phase 2 cell capacity (3.6 GW) to start site activities by Q2 FY27, complete by FY28
Capex incurred INR1,000 Cr; total Phase 1 and 2 capex ~INR3,500 Cr; net debt expected to peak ~INR2,200-2,400 Cr
Margin pressure in Q1 due to lack of cell manufacturing, commodity, logistics, forex volatility, and selective order execution
Q1 FY27 production 408 MW, sales 334 MW; revenue INR5.11bn, EBITDA INR425mn (8.33% margin), PAT INR54mn
FY27 guidance: 3.5-4 GW sales, INR6,000 Cr revenue, 12% EBITDA margin, 6-7% PAT margin
Odisha Phase 1 cell (2.4 GW) and module (4 GW) manufacturing ramp-up starting Sep 2026; full 80% utilization expected by Q4 FY27

Fiem Industries Limited FIEMIND Q1FY27 📝 Transcript · Automobile and Auto Components

Filed 18 Aug 2026

FY27 margin guidance around 14%, with raw material cost pass-through expected over quarters
Capex of INR41 Cr in Q1; full year capex guidance INR100 Cr, mainly for Hosur plant expansion
FY27 revenue growth guidance: 15-20%
4-wheeler business remains ~2.5% of revenue; meaningful growth expected from FY28 onwards
LED lighting share in revenue at 63% (value basis), expected to rise to ~70% in 24-30 months
EV segment volume share rose to 9% in Q1; EV platforms carry higher LED lighting content

Diffusion Engineers Limited DIFFNKG Q1FY27 📝 Transcript

Filed 18 Aug 2026

Order book at INR209 cr, up 20.4% sequentially; >80% executable in FY27
Consolidated Q1 FY27 revenue grew 36.5% y-y to INR1101.08 mn; EBITDA rose 33.76% y-y to INR141.54 mn; EBITDA margin 12.85% vs 13.12% y-y; PAT increased 35.98% y-y to INR166.77 mn
Standalone Q1 FY27 revenue up 30.72% y-y to INR959.13 mn; EBITDA grew 40.44% y-y to INR121.54 mn; EBITDA margin 12.67%
FY27-FY28 revenue growth guidance ~20% CAGR; EBITDA margin expected to improve 100-200 bps
Raw material prices remain high but stabilized; margin contraction ~100-150 bps due to price volatility
INR100 cr capacity expansion underway, heavy engineering capacity doubling to 18,000 MT; phased commissioning started

Yatharth Hospital & Trauma Care Services Limited YATHARTH Q1FY27 📝 Transcript · Healthcare

Filed 18 Aug 2026

Capacity at 2,555 beds; target 5,000 beds within ~2.5 years, including Gurugram opening Q1FY28
EBITDA margin adjusted for new hospitals at 28.1%; group targets 24-25% EBITDA margin for FY27
New hospitals expected to reach 15-20% EBITDA margin within 15 months post breakeven
ARPOB growth guidance 8-10% y-y; revenue growth and margins expected to surpass FY26 levels
Capex per bed rising to INR75-80 lakhs due to equipment and real estate costs
Q1FY27 revenue reached INR3,927 million, up 51% y-y; EBITDA INR917 million, PAT INR454 million

Aditya Infotech Limited CPPLUS Q1FY27 📝 Transcript · Capital Goods

Filed 18 Aug 2026

New product launches: CP PLUS Pro series (Q3-Q4 FY27), Home IoT devices, industrial robots, drone cameras
Market share 43.3% in Indian video surveillance FY26; strong brand moat and distribution
Q1 FY27 revenue 1,402 Cr +89.5% y-y; EBITDA 208 Cr +20%, margin 14.8% +604 bps y-y; PAT 142.2 Cr +332.5% y-y
Backward integration in housing, cables, lenses to add margin basis points; scale-up from Q3 FY27
Price hikes of 10-20% taken gradually; total expected ~25% for FY27
Manufacturing capacity 2.5 mn units/month, 85-90% utilization; capacity doubling planned over 3 years

Senco Gold Limited SENCO Q1FY27 📝 Transcript · Consumer Durables

Filed 18 Aug 2026

Q1 FY27 consolidated revenue grew 67% YoY, retail sales up 50%, same-store sales +39%
Sustainable EBITDA margin guidance retained at 7.5%-7.8%; customs-duty gain ~INR 12-15 crores
Target EBITDA margin ~8%, PAT margin 4.5%-5%, ROE/ROCE near 20%
FY27 guidance 20%+ value growth; long-term target INR 20,000+ crores revenue, 300+ stores
Diamond jewellery sales +43% value, +18% volume; shift to lightweight, design-led jewellery
EBITDA INR 213 crores at 7.0% margin; consolidated PAT INR 101 crores at 3.3%

Vodafone Idea Limited IDEA Q1FY27 📝 Transcript · Telecommunication

Filed 18 Aug 2026

Guidance: 3x cash EBITDA in 3 years with 16.8% CAGR; 55-57k 4G sites and 86-90k 5G sites by FY29
Capex of Rs. 1,930 Cr in Q1; Rs. 9,000 Cr orders placed for network expansion
Multiple analyst queries on subscriber trends, ARPU growth drivers, and capex deployment
Q1FY27 revenue grew 6.0% YoY to Rs. 11,689 Cr; Cash EBITDA up 13.5% to Rs. 2,475 Cr
Subscriber base increased to 193.1 million; first positive net addition quarter since merger
Customer ARPU rose 10.2% YoY to Rs. 195; 4G/5G mix improved to 67.4%

Finolex Cables Limited FINCABLES Q1FY27 📝 Transcript · Capital Goods

Filed 18 Aug 2026

Fiber cable capacity expanding from 4 to 8 million km by Q2 FY27; cabling capacity to 10 million
Data center fiber demand growing; R&D and capex underway for high-fiber-count cables
Margin outlook: electrical cables sustainable ~10.5%, communication cables margins to normalize but stay double-digit
Multiple analyst queries on margin sustainability and fiber capacity utilization; management cautious on margin normalization
Q1 FY27 revenue grew 44% y-y to INR 2,013 Cr; PAT rose 59% to INR 221 Cr
Electrical cables revenue up 47%, led by auto, solar, agriculture segments

Zydus Lifesciences Limited ZYDUSLIFE Q1FY27 📝 Transcript · Healthcare

Filed 18 Aug 2026

Capex guidance ₹1,500-1,600 Cr for FY27; investments in SEZ expansion, R&D, CAR-T, vaccines
Q1 FY27 consolidated revenue ₹80.2bn +22% y-y; EBITDA ₹19.3bn, margin 24.1%; PAT ₹9.4bn
EBITDA margin guidance maintained at 24%+ despite Saro investment ramp-up in H2 FY27
International formulations revenue ₹9.7bn +34% y-y; North America revenue ₹31bn, US generics filings and launches strong
Consumer wellness revenue ₹14.3bn +67% y-y; international business +25%, domestic skin & hair care +35%
Multiple analyst queries on US branded growth, Saro launch timeline, biosimilars scale-up, and Assertio acquisition impact

🎙 Transcript Summaries